<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib13">
 <label>13</label>
 <element-citation publication-type="journal" id="sbref130">
  <person-group person-group-type="author">
   <name>
    <surname>Ferreri</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>Cwynarski</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Pulczynski</surname>
    <given-names>E</given-names>
   </name>
  </person-group>
  <article-title>Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial</article-title>
  <source>Lancet Haematol</source>
  <volume>3</volume>
  <year>2016</year>
  <fpage>e217</fpage>
  <lpage>e227</lpage>
  <pub-id pub-id-type="pmid">27132696</pub-id>
 </element-citation>
</ref>
